Can I Take Ashwagandha with TB-500?

What Is TB-500 and How Does It Work?

TB-500 is a synthetic analogue of thymosin beta-4, a naturally occurring 43-amino-acid peptide expressed in nearly every cell type in the human body. The compound promotes actin polymerization, reduces inflammation through down-regulation of NF-kB signaling, and accelerates migration of endothelial cells and keratinocytes to injury sites [1]. Researchers have studied it in models of cardiac repair, tendon healing, and wound closure.

Mechanism of Action

The active fragment binds actin monomers (G-actin) via its LKKTETQ motif, sequestering them and enabling rapid cytoskeletal remodeling [2]. This is mechanistically distinct from growth hormone or IGF-1 pathways, which matters because it means TB-500 does not directly stimulate the GH axis or aromatase.

Dosing and Administration

In compounded protocols reviewed at 503A pharmacies, typical dosing runs 2 to 5 mg subcutaneously two times per week for a 4 to 6 week loading phase, followed by 2 to 2.5 mg once weekly for maintenance. No FDA-approved dosing exists because the compound is not approved for human use [3]. Patients obtain it through compounding pharmacies operating under the Drug Quality and Security Act.

Regulatory Status

The FDA has not approved TB-500 for any indication [3]. Clinicians prescribing it through 503A pharmacies do so off-label, and all human data remain observational or extrapolated from animal studies.

What Is Ashwagandha and What Does It Do Hormonally?

Ashwagandha (Withania somnifera) is an adaptogenic root extract with the most clinical evidence of any adaptogen in the peer-reviewed literature. Its primary active constituents are withanolides, a class of steroidal lactones that modulate the hypothalamic-pituitary-adrenal (HPA) axis [4].

Cortisol Reduction

A randomized, double-blind, placebo-controlled trial published in Medicine (N=60) found that 240 mg of ashwagandha root extract daily for 60 days reduced serum cortisol by 23% and self-reported stress scores by 44% compared with placebo [5]. A separate 2019 RCT (N=60) using 300 mg KSM-66 twice daily reported a 27.9% reduction in serum cortisol at 8 weeks [6]. These reductions are clinically meaningful because cortisol suppression improves tissue repair signaling, which overlaps with TB-500's intended effect.

Testosterone and Reproductive Hormones

A 2019 pilot study (N=43) in overweight men showed that 600 mg ashwagandha daily for 8 weeks raised serum testosterone by 14.7% and DHEA-S by 18% compared with placebo [7]. A 2010 study in infertile men (N=75) found a 17% increase in testosterone and significant improvements in sperm parameters after 90 days of 5 g root powder [8]. These androgenic effects are modest but additive if a patient is simultaneously using protocols that raise androgen levels.

Thyroid Effects

Ashwagandha raised serum T4 by 19.6% and T3 by 11.4% in a small trial of 18 adults with subclinical hypothyroidism [9]. Anyone with hyperthyroidism, Graves' disease, or autoimmune thyroid conditions should have TSH and free T4 measured before starting ashwagandha, regardless of TB-500 use.

Does TB-500 Affect Cortisol or Hormones?

TB-500 does not directly bind glucocorticoid receptors, and no published human trial has measured its effect on serum cortisol. Animal data suggest it reduces pro-inflammatory cytokines (IL-1beta, TNF-alpha) via NF-kB suppression [10], which may indirectly lower HPA-axis activation. The effect, if real in humans, would point in the same direction as ashwagandha's cortisol-lowering action.

Thymosin Beta-4 and the HPA Axis

Thymosin beta-4 is expressed in the anterior pituitary and has been detected in cerebrospinal fluid [11]. Some researchers hypothesize a modulatory role in pituitary signaling, but no controlled human data confirm this. Patients combining TB-500 with ashwagandha should be aware that both agents may lower cortisol simultaneously, which could be relevant for individuals who rely on normal cortisol for blood pressure regulation or immune defense.

TB-500 and Testosterone

No published trial has shown TB-500 directly raising testosterone. Its anti-inflammatory effects may theoretically support Leydig cell function by reducing intratesticular oxidative stress, but this remains speculative [12]. The testosterone-raising effect of the combination is likely driven by ashwagandha, not TB-500.

Pharmacokinetic vs. Pharmacodynamic Interaction: What Type Is This?

This is a pharmacodynamic interaction, not a pharmacokinetic one. Here is the distinction and why it matters clinically.

Pharmacokinetic Interaction (Not Present Here)

A pharmacokinetic interaction occurs when one substance alters the absorption, distribution, metabolism, or excretion of another. TB-500 is a peptide degraded by proteolytic enzymes; ashwagandha withanolides are metabolized primarily through hepatic CYP3A4 [13]. No published data show withanolides inhibiting or inducing CYP3A4 at clinically relevant doses. Because TB-500 bypasses oral hepatic first-pass metabolism entirely (it is injected), the two compounds do not share a metabolic pathway.

Pharmacodynamic Interaction (Present, Low Severity)

A pharmacodynamic interaction occurs when two agents act on the same physiological target. Both TB-500 and ashwagandha may lower cortisol and reduce systemic inflammation through overlapping but distinct mechanisms. The Beers Criteria and Natural Medicines Database classify additive cortisol-lowering combinations as a minor to moderate concern only in patients with adrenal insufficiency or those on exogenous corticosteroids [14]. For healthy adults, additive cortisol lowering is generally favorable for tissue repair and recovery.

Potential Benefits of Combining TB-500 and Ashwagandha

The theoretical case for this stack rests on complementary mechanisms operating in tissue repair and recovery.

Cortisol Reduction Amplifies Anabolic Signaling

High cortisol suppresses protein synthesis and impairs satellite cell activation in skeletal muscle [15]. Ashwagandha's documented 23 to 28% cortisol reduction could create a lower-cortisol environment in which TB-500's pro-repair signaling operates more efficiently. This logic is mechanistically sound, even if no direct human trial has tested the combination.

Anti-Inflammatory Combination Without Immune Suppression

TB-500 down-regulates NF-kB-mediated cytokine release [10]. Ashwagandha's withanolides, particularly withaferin A, also inhibit NF-kB in a dose-dependent manner in vitro [16]. The combination may produce a broader anti-inflammatory profile than either compound alone, which could benefit athletes recovering from soft-tissue injury. Unlike NSAIDs or corticosteroids, neither agent systemically suppresses the immune response at typical doses, so infection risk is not a stated concern in the literature.

Connective Tissue and Muscle Recovery

A 2015 RCT (N=57) found that 300 mg ashwagandha twice daily for 8 weeks improved muscle recovery, reduced exercise-induced muscle damage markers (creatine kinase), and increased muscle size compared with placebo [17]. TB-500's role in tendon and cardiac tissue repair is supported by murine models showing accelerated collagen deposition [18]. Combining an agent that reduces muscle damage markers with one that may accelerate structural repair is theoretically additive for athletic recovery.

Risks and Cautions When Combining These Two Agents

Cortisol That Goes Too Low

Additive cortisol suppression is generally safe in otherwise healthy people. The concern surfaces in three specific populations: patients with Addison's disease or adrenal insufficiency, patients on prescription corticosteroids, and patients using other HPA-axis modulants (phosphatidylserine, rhodiola, high-dose magnesium) simultaneously [14]. Morning serum cortisol below 10 mcg/dL warrants clinical evaluation before continuing either compound.

Thyroid Overstimulation

Ashwagandha's documented T3/T4 elevation [9] means anyone with pre-existing hyperthyroidism should not start ashwagandha without physician oversight, regardless of TB-500 use. For euthyroid adults, the modest T4 increase is unlikely to cause harm, but a baseline TSH provides a meaningful reference point.

Androgenic Load in Testosterone-Sensitive Conditions

Ashwagandha's modest testosterone elevation (14 to 17%) is relevant for patients with hormone-sensitive prostate conditions, polycystic ovary syndrome, or those already on TRT. TB-500's contribution to androgenic load appears negligible based on current evidence. Still, measuring total and free testosterone at baseline before starting a stack is standard practice at HealthRX.

Unknown Long-Term Safety of TB-500 in Humans

This caveat applies to TB-500 regardless of co-administration. No long-term human safety trials exist. The FDA has not evaluated the compound [3], and adverse-event reporting is limited to case reports and compounding-pharmacy observational data. Patients should treat 6 to 8 week cycles as the outer limit until more data are available.

Dose-Separation: Do You Need to Time These Differently?

No pharmacokinetic evidence requires time-of-day separation between TB-500 injections and ashwagandha capsules. They do not share a metabolic pathway that would demand spacing. Practical guidance follows.

Ashwagandha Timing

Most clinical trials dosed ashwagandha with meals to reduce gastric irritation [6]. A 300 mg dose with breakfast and 300 mg with dinner mirrors the KSM-66 trials that produced the strongest cortisol and testosterone data.

TB-500 Injection Timing

Injection timing relative to training is debated in the practitioner community. Some 503A prescribers recommend injecting 30 to 60 minutes before training to theoretically prime repair signals during the injury window. No controlled trial has validated this recommendation.

What to Do If You Are Already Taking Both

If you are already combining the two agents and experiencing no adverse symptoms, no change is required. Order a baseline lab panel (AM cortisol, TSH, free T4, total testosterone, LH, FSH, CBC with differential) and recheck at 8 weeks. Document injection site reactions, energy changes, and sleep quality, as these are the earliest subjective signals of HPA-axis dysregulation.

Monitoring Protocol at HealthRX

A structured monitoring approach reduces the chance that subclinical changes go unnoticed.

Baseline Labs (Before Starting)

• AM serum cortisol (draw before 9 AM)
• TSH and free T4
• Total testosterone and free testosterone
• LH and FSH
• CBC with differential
• Comprehensive metabolic panel

8-Week Recheck

Repeat AM cortisol, TSH, free T4, and total testosterone. Compare to baseline. A cortisol drop exceeding 40% from baseline, or a TSH below 0.4 mIU/L, warrants pausing ashwagandha and re-evaluating.

12-Week and Beyond

If the 8-week panel is stable, recheck every 12 weeks while continuing the stack. Athletes using TB-500 for injury recovery typically run 4 to 6 week loading phases; the monitoring schedule should align with cycle boundaries.

Special Populations

Women

Ashwagandha's testosterone-raising effect was studied predominantly in men. In women, a 2021 RCT (N=50) showed that 300 mg KSM-66 twice daily improved sexual function scores and DHEA-S without clinically significant testosterone elevation [19]. TB-500 has no sex-specific safety data in humans. Women who are pregnant or breastfeeding should not use either compound; ashwagandha has uterotonic properties documented in animal models [20].

Older Adults

The anti-inflammatory profile of both agents may be particularly relevant for adults over 50 managing tendon degeneration or chronic low-grade inflammation. Cortisol dysregulation is more common in older adults, making the baseline-lab requirement more important, not less.

Patients on TRT or HRT

Adding ashwagandha's modest testosterone boost to an existing TRT protocol requires recalculation of TRT dose with your prescribing physician. TB-500 alone does not appear to alter the TRT dose-response based on current evidence.